Taro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Gross Profit

Gross Profit analysis for TARO.

Quarterly Gross Profit

$87.39M

↑ 15.43% YoY

As of Mar 31, 2024

Annual Gross Profit (TTM)

$304.96M

↑ 13.65% YoY

Trailing 12 months ending Mar 31, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin